Category: genetic engineering

Aids biology biotechnology China CRISPR Emerging-Technologies genetic engineering Hiv Shenzhen TC World Health Organization

The World Health Organization is setting up rules and oversight for human gene editing

sudshr47 March 20, 2019

Yesterday, the World Health Organization wrapped up its first meeting of a new advisory committee set up to create global governance and oversight standards for human gene editing. The committee was hastily pulled together in December after the revelation last year that a Chinese scientist had genetically modified two embryos using CRISPR technology to remove the […]

View More The World Health Organization is setting up rules and oversight for human gene editing
Artis Ventures biology biotechnology CRISPR CRISPR Therapeutics Disease Editas Medicine executive genetic engineering Genetics infection Intellia Therapeutics johnson & johnson locus biosciences North Carolina North Carolina State University Science Synthego TC Tencent

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies

sudshr47 January 4, 2019

The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene editing technologies and (potentially) the whole field of microbiome-targeted therapies. Based in Research Triangle Park, N.C., Locus is commercializing research initially developed by scientists at […]

View More Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies